Replies to post #190127 on Biotech Values

[alexander77]

The next financials will show the positive consequences of the reduction in costs by one-two million dollars/quarter. You can expect a growth in revenues, another FDA approval which will accept that the the SiN material is equal to PEEK the current standard of care, but SiN is much stronger and can sustain in the body for a a longer period, no bacterial infection, ...

By the way the company has more cash than their market cap: $18m in cash versus $7m market cap!!!

They messed it up, but are back on track now. 26 million shares outstanding currently, and if fully diluted they will have less than 70 m shares outstanding.
The share price is raped, it should be around $1-2/share depending which formulas you use to calculate the market cap.

[marthambles]

AMDA

To which product are you referring? The entire silicon nitride platform?

[chantillylive]

AMDA

xrymd... Are you adding shares today? I too think this is an interesting company. Horrible financing, yet, a very interesting company nonetheless.

TIA.

cl

[chantillylive]

AMDA... xrymd...

Any thoughts on AMDA's future reference finance, FDA, PPS?

Thanks for the heads-up on AMDA. It is an interesting company. And, profitable to date.

cl.